基本信息
浏览量:143
职业迁徙
个人简介
Dr. Coutts moved to Calgary to complete a Fellowship in Stroke Neurology with Dr. Alastair Buchan and completed her Neurology Residency Training, receiving her FRCPC (Neurology) in 2006. During her stroke neurology training, she completed a postgraduate research degree on “Modern imaging: its role in prediction of outcome after stroke and TIA” and she received her MD (PhD equivalent) for this from the University of Edinburgh in 2005.
Her research interests include the use of acute imaging in triage and treatment of stroke and TIA patients in the Emergency Department. She plans to design therapeutic trials in high risk TIA and minor stroke using imaging to identify patients.
She is running the TEMPO-1 study. This is phase 2, dose escalation, safety study using low dose TNK in the treatment of minor stroke with intracranial occlusion. Currently, she is also coordinating a project to reduce the rate of stroke after a TIA throughout the province of Alberta. Her work is funded by The Heart and Stroke Foundation of Canada, the Canadian Institutes of Health Research and by a Pfizer cardiovacsular research award.
Dr. Coutts has received a number of awards for her work, including the “Siekert New Investigator Award” from the American Stroke Association, the "Michael J. Pessin award" in stroke leadership from the American Academy of Neurology and the Petro Canada Young Innovator Award in Community Health. She is the first recipient of the Heart and Stroke Foundation of Canada Distinguished Clinician Scientist award, supported in partnership with the CIHR Institute of Circulatory and Respiratory Health and AstraZeneca Canada Inc. She also hold a clinical investigator award from the Alberta Heritage Foundation for Medical Research.
Her research interests include the use of acute imaging in triage and treatment of stroke and TIA patients in the Emergency Department. She plans to design therapeutic trials in high risk TIA and minor stroke using imaging to identify patients.
She is running the TEMPO-1 study. This is phase 2, dose escalation, safety study using low dose TNK in the treatment of minor stroke with intracranial occlusion. Currently, she is also coordinating a project to reduce the rate of stroke after a TIA throughout the province of Alberta. Her work is funded by The Heart and Stroke Foundation of Canada, the Canadian Institutes of Health Research and by a Pfizer cardiovacsular research award.
Dr. Coutts has received a number of awards for her work, including the “Siekert New Investigator Award” from the American Stroke Association, the "Michael J. Pessin award" in stroke leadership from the American Academy of Neurology and the Petro Canada Young Innovator Award in Community Health. She is the first recipient of the Heart and Stroke Foundation of Canada Distinguished Clinician Scientist award, supported in partnership with the CIHR Institute of Circulatory and Respiratory Health and AstraZeneca Canada Inc. She also hold a clinical investigator award from the Alberta Heritage Foundation for Medical Research.
研究兴趣
论文共 365 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Andy Lim,Peter M. Rothwell,Linxin Li,Shelagh B. Coutts,Michael D. Hill,Maria Guarino,Valentina Barone,Francesca Rondelli,Timothy Kleinig, Reid Cornell-Farrow, Martin Krause,Miriam Wronski,
FRONTIERS IN NEUROLOGY (2024): 1351769-1351769
NEUROLOGYno. 1 (2024): e207846-e207846
Radhika Nair,Nishita Singh,Mahesh Kate,Negar Asdaghi, Robert Sarmiento,Fouzi Bala,Shelagh B. Coutts,MacKenzie Horn,Alexandre Y. Poppe,Heather Williams,Ayoola Ademola,Ibrahim Alhabli,
STROKE AND VASCULAR NEUROLOGY (2024)
Strokeno. 3 (2024): 524-531
Circulationno. 10 (2024): 797-798
Journal of the American Heart Associationpp.e032471-e032471, (2024)
Margaret Moores,Raed A Joundi,Nishita Singh,Andrew M Penn,Kristine Votova,Eric E Smith,Shelagh B Coutts
Journal of the American Heart Associationno. 7 (2024): e033817-e033817
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn